foxo4-dri senolytic peptide baar 2017 cell Development of a novel by precise disruption of FOXO4-p53 complex Cellular Senescence in Health, Disease,
Cellular Senescence in Health, Disease, and Lens Aging Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI Peptide Nationwide Peptides By National Science Labs, LLC Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $6.33 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




